Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

SOX4 is crucial for the development of melanoma.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

Keratin mutations may cause scarring alopecia by damaging hair structure.

LC-OCT can help diagnose different types of scarring alopecia.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Keratoacanthoma and some squamous cell carcinomas are linked to hair follicles, while others are not.

New mutations in the SLC39A4 gene found in twins help understand the genetic cause of acrodermatitis enteropathica.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

The study identified key immune cell differences between mild and severe alopecia areata.

The tumor suppressor BRCA2 helps in cell division by bringing key proteins to the area where cells split.

LRIG1 is linked to better survival in Merkel cell carcinoma.

HDAC1 is crucial for skin development and preventing tumors.

Immune therapy for cancer can cause hair loss scars in some patients.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

The girl has an inflammatory type of scarring hair loss.

ICAM-1 helps regulate hair growth cycles and skin remodeling.

RAR-gamma 1 is important for normal skin maintenance and differentiation.

Human basal cell carcinomas and squamous cell carcinomas have unique gene expression patterns not fully mirrored in mouse models.

A rare genetic mutation causes severe immune issues, hair loss, and nail problems.

Rare skin cancer can mimic hair loss conditions, so thorough diagnosis is crucial.

High lactate dehydrogenase activity is not necessary for the growth of squamous cell carcinoma.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.